European Archives - Page 32 of 1095 - European Medical Journal

Pfizer completes exit from Haleon

Pfizer has announced plans to sell its remaining stake in Haleon plc, divesting approximately 662 million shares.

Neurodegeneration and Cardiovascular Health: New Insights on Racial Differences

Better heart health cuts neurodegeneration biomarkers by 19% in the elderly, but racial disparities in CVH highlight need for targeted interventions.

Meet the Experts: What to do with a positive urine marker test?

Join Dr Fred Witjes & Dr Param Marappian as they discuss the latest innovations in the use of biomarkers to diagnose and test for urine…

AI-Driven Platform Predicts Outcomes in High-Risk Bladder Cancer

Notably, AI-driven models outperformed traditional clinical risk calculators like the EORTC and EAU models.

Apolipoprotein A-I Identified as Protective Factor in COPD

New research has identified a potential causal relationship between lipid metabolism and chronic obstructive pulmonary disease.

Probiotic Mixture Could Reduce Fever Duration in Children with URTIs

A recent study shows probiotics reduce fever duration by two days in children with URTIs, potentially providing a safe treatment option.

What is the Link Between Parkinson’s and Autism? ITSN1 Gene Reveals All

ITSN1 gene variant raises Parkinson’s risk tenfold, with links to autism. Breakthrough study reveals dual neurological threat.

5 minutes with... Prof Alexander Egeberg, LEO Pharma

Prof Alexander Egeberg, Vice President, Head of Global Medical Affairs, LEO Pharma, reveals how the company is tackling unmet needs in dermatology.

19 Mar 2025

Improving Management of Food Allergy

The symposium was held on the final day of the European Academy of Allergy and Clinical Immunology’s (EAACI) Food Allergy and Anaphylaxis…

Too Much TV? Heart Disease Risk Rises in Patients Prone to Type 2 Diabetes

People with a genetic risk for type 2 diabetes may face a greater threat to heart health if they spend too much time watching TV, according to a new study.